Role of allergy in rhinosinusitis

Current Opinion in Allergy and Clinical Immunology

Volumn 4, Issue 1, 2004, Pages 17-23

  Kirtsreesakul, Virat ^a   Naclerio, Robert M ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MC 1035 ^*  (United States)

Author keywords

Allergy; Cytokines; Eosinophils; Fungus; Intranasal steroids; Lymphocytes; Rhinitis; Sinusitis; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; HISTAMINE;

ALLERGIC RHINITIS; ALLERGY; CELLULAR IMMUNITY; EOSINOPHIL; HEALTH CARE COST; HUMAN; INFLAMMATORY CELL; INSOMNIA; MAST CELL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHINOSINUSITIS; T LYMPHOCYTE;

HUMANS; PREVALENCE; RHINITIS, ALLERGIC, PERENNIAL; SINUSITIS;

EID: 4143081317     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200402000-00005     Document Type: Review

References (71)

1. Snow V, Mottur-Pilson C, Hickner J. Principle of appropriate antibiotic use for acute sinusitis in adults. Ann Intern Med 2001; 20:495-497.
2. Dykewicz MS, Fineman S. Parameters on diagnosis and management of rhinitis. Ann Allergy Asthma Immunol 1998; 81:465-468.
3. Savolainen S. Allergy in patients with acute maxillary sinusitis. Allergy 1989; 44:116-122.
4. Chen CF, Wu KG, Hsu MC, Tang RB. Prevalence and relationship between allergic disease and infectious diseases. J Microbiol Immunol Infect 2001; 34:57-62.
5. Walker C, Williams H, Phelan J. Allergic rhinitis history as a predictor of other future disqualifying otorhinolaryngological defects. Aviat Space Environ Med 1998; 69:952-956.
6. Holzmann D, Willi U, Nadal D. Allergic rhinitis as a risk factor for orbital complication of acute rhinosinusitis in children. Am J Rhinol 2001; 15:387-390.
7. Parsons DS, Wald ER. Otitis media and sinusitis: similar disease. Otoloaryngol Clin North Am 1996; 29:11-19.
8. Krause HF. Allergy and chronic rhinosinusitis. Otolaryngol Head Neck Surg 2003; 128:14-16.
9. Pelikan Z, Pelikan-Filipek M. Role of nasal allergic rhinitis in chronic maxillary rhinosinusitis: diagnosis value of nasal challenge with allergen. J Allergy Clin Immunol 1990; 86:484-491.
10. Naclerio RM, deTineo ML, Baroody FM. Ragweed allergic rhinitis and the paranasal sinuses: a computed tomographic study. Arch Otolaryngol Head Neck Surg 1997; 123:193-196.
11. Berrettini S, Carabelli A, Sellari-Franceschini S, et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy 1999; 54:242-248.
12. Adkins TN, Goodgold HM, Hendershott L, Slavin RG. Does inhaled pollen enter the sinus cavities? Ann Allergy Asthma Immunol 1998; 81:181-184.
13. Gwaltney JM, Hendley JO, Phillips CD, et al. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis 2000; 30:387-391.
14. Naclerio RM, Baroody FM, Nalini B, et al. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone. Otolaryngol Head Neck Surg 2003; 128:220-227. A parallel randomized study that compared nasal clearance as an adverse effect of topical corticosteroids between budesonide and mometasone in treatment of perennial allergic rhinitis.
15. Peebles RS, Hashimoto K, Graham BS. The complex relationship between respiratory syntytial virus and allergy in lung disease. Viral Immunol 2003; 16:25-34.
16. Sotir M, Yeatts K, Shy C. Presence of asthma risk factors and environmental exposures related to upper respiratory infection-triggered wheezing in middle school-age children. Environ Health Perspect 2003; 111:657-662. This article describes a population-based study that evaluated difference in environmental exposures between symptomatic middle school-age children who did and did not have wheezing triggered by viral respiratory infections.
17. Stephens R, Randolph DA, Huang G, et al. Antigen-nonspecific recruitment of Th2 cells to lung as a mechanism for viral infection-induced allergic asthma. J Immunol 2002; 169:5458-5467. A mouse model was used to describe the mechanism of viral infection induced allergic asthma, illustrating the role of the antigen specificity of Th1 cells in the enhancement of Th2 cell recruitment.
18. Harlin SL, Ansel DG, Lane SR, et al. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 1988; 81:867-875.
19. Suzuki M, Watanabe T, Suko T, Mogi G. Comparison of rhinosinusitis with and without allergic rhinitis: characteristics of paranasal sinus effusion and mucosa. Am J Otoloaryngol 1999; 20:143-150.
20. Elwany S, Bassyouni M, Morad F. Some risk factors for refractory chronic sinusitis: an immunohistochemical and electron microscopic study. J Laryngol Otol 2002; 116:112-115. This study used immunohistochemistry and electromicroscopy to evaluate the role of eosinophilic infiltration and mast cell degranulation in the sinus mucosa of patients with refractory chronic rhinosinusitis.
21. Baroody FM, Anthony HC, Philip M, et al. Eosinophilia in chronic childhood sinusitis. Arch Otolaryngol Head Neck Surg 1995; 121:1396-1402.
22. Hamilos DL, Leung DYM, Wood R, et al. Evidence for distinct cytokine expression in allergic versus non-allergic chronic sinusitis. J Allergy Clin Immunol 1995; 96:537-544.
23. Hamilos DL, Leung DYM, Wood R, et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte- macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol 1993; 92:39-48.
24. α. Am J Respir Cell Mol Biol 1996; 15:443-450.
25. Boyce JA. Mast cells: beyond IgE. J Allergy Clin Immunol 2003; 111:24-32.
26. Driscoll PV, Naclerio RM, Baroody FM. CD4+ lymphocytes are increased in the sinus mucosa of children with chronic sinusitis. Arch Otolaryngol Head Neck Surg 1996; 122:1071-1076.
27. Blair C, Nelson M, Thomson K, et al. Allergic inflammation enhances bacterial sinusitis in mice. J Allergy Clin Immunol 2001; 108:424-429.
28. Jyonouchi H, Sun S, Rimell F. Cytokine production by sinus lavage, bronchial lavage, and blood mononuclears in chronic rhinosinusitis with or without atopy. Arch Otolaryngol Head Neck Surg 2000; 126:522-528.
29. Riccio AM, Tosca MA, Cosentino C, et al. Cytokine pattern in allergic and non-allergic chronic rhinosinusitis in asthmatic children. Clin Exp Allergy 2002; 32:422-426. This study analyzed the cytokine pattern in asthmatic children with chronic rhinosinusitis and compared the findings among allergic and nonallergic asthmatic patients and healthy controls.
30. Ghamdi KA, Ghaffar O, Small P, et al. IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment. J Otolaryngol 1997; 26:160-166.
31. Wright ED, Frenkiel S, AJ-Ghamdi K. Interleukin-4, interleukin-5, and granulocyte-colony-stimulating factor receptor expression in chronic sinusitis and response to topical steroids. Otolaryngol Head Neck Surg 1998; 118:490-495.
32. Ferguson BJ, Johnson JT. Allergic rhinitis and rhinosinusitis: is there a connection between allergy and infection? Postgrad Med 1999; 105:55-58.
33. Slavin RG, Zilliox AP, Samuels LD. Is there such an entity as allergic rhinosinusitis? [abstract]. J Allergy Clin Immunol 1988; 81:284.
34. Braunstahl GJ, Kleinjan A, Overbeek SE, et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000; 161:2051-2057.
35. Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001; 164:858-865.
36. Baroody FM, Saengpanich S, deTineo M, et al. Nasal allergen challenge leads to bilateral maxillary sinus easinophil influx [abstract]. J Allergy Clin Immunol 2002; 109:S216. A study demonstrating an influx of eosinophils in both maxillary sinuses after antigen nasal challenge of one nasal cavity, giving insight into a neurogenic inflammation mechanism.
37. Schleimer RP, Togias AG. Introduction: systemic aspects of allergic disease. J Allergy Clin Immunol 2000; 106:S191.
38. Feger TA, Rupp NT, Kuhn FA, et al. Local and systemic eosinophil activation in allergic fungal sinusitis. Ann Allergy Asthma Immunol 1997; 79:221-225.
39. Stewart AE, Hunsaker DH. Fungus-specific IgG and IgE in allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg 2002; 127:324-332. This prospective study shows the role of fungus-specific IgG and IgE in allergic fungal rhinosinusitis.
40. Khan DA, Cody T, George TJ, et al. Allergic fungal rhinosinusitis: an immunohistologic analysis. J Allergy Clin Immunol 2000; 106:1096-1101.
41. Ponikau J, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74:877-884.
42. Karp MW, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2002, 1:69-75.
43. Allmers H, Schmengler J, Skudlik C. Primary prevention of natural rubber latex allergy in the German health care system through education and intervention. J Allergy Clin Immunol 2002; 88:16-22. Showed that intervention programs to reduce latex exposure lead to primary prevention of latex allergy. Good evidence suggests the importance of allergen avoidance in treatment of allergic disease.
44. Terreehorst I, Hak E, Oosting AJ, et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med 2003; 349:237-246. A multicenter, randomized, placebo-controlled trial evaluating the benefit of mite-proof bedding covers as part of allergy avoidance in the treatment of allergic rhinitis. The study showed that this single avoidance measure did not improve clinical symptoms.
45. Naclerio RM, Kagey-Sobotka A, Lichtenstein LM. Terfenadine, H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990; 142:167-171.
46. Walsh GM. The clinical relevance of the anti-inflammatory properties of antihistamines. Allergy 2000; 55:53-61.
47. Braun JJ, Alabert JP, Michel FB, et al. Adjunct effect of loraladine in the treatment of acute sinusitis in patients with allergic rhinitis. Allergy 1997; 52:650-655.
48. Borish L. The role of leukotrienes in upper and lower airway inflammation and the implications for treatment. Ann Allergy Asthma Immunol 1996; 105:222-225.
49. Steinke JW, Bradley D, Arango P, et al. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma. J Allergy Clin Immunol 2003; 111:342-349. The study demonstrated increased expression of cysteinyl leukotrienes in chronic hyperplastic sinusitis, suggesting the role of leukotriene modifiers as a part of treatment.
50. Bascom R, Wachs M, Nacleno RM, et al. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988; 81:580-589.
51. Pipkorn U, Proud D, Lichtenstein LL, et al. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticoids. N Engl J Med 1987; 316:1506-1510.
52. Siegel SC, Katz R, Rachelefsky G, et al. Multicenter study of beclomethasone dipropriate in adults with seasonal allergic rhinitis. J Allergy Clin Immunol 1982; 69:345-353.
53. Johansen LV, Illum P, Kristensen S, et al. The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps. Clin Otolaryngol 1993; 18:524-527.
54. Ruhno J, Andersson B, Denberg J, et al. A double-blind comparison of intranasal budesonide with placebo for nasal polyps. J Allergy Clin Immunol 1990; 86:946-953.
55. Lildholt T, Rundcrantz H, Lindquist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol 1995; 20:26-30.
56. Berggren F, Johansson L. Cost effectiveness of nasal budesonide versus surgical treatment for nasal polyps. Pharmacoeconomics 2003; 21:351-356. The study showed that initial treatment of nasal polyps with topical corticosteroids incurs lower cost than does initial surgical treatment with similar effectiveness.
57. Barlan IB, Erkan E, Bakir M, et al. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol 1997; 78:598-601.
58. Dolor TJ, Witsell DV, Helkamp AS, et al. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. JAMA 2001; 286:3097-3105.
59. Meltzer EO, Orgel AH, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993; 92:812-823.
60. Meltzer EO. Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study. Clinical therapeutics 2002; 24:942-952. A multicenter, randomized, double-blind, placebo-controlled, parallel-group study showing the efficacy of cromolyn sodium nasal solution for the treatment of allergic rhinitis in self-selected patients in a nonprescription setting.
61. Birchall MA, Henderson JC, Studham JM, et al. The effect of topical sodium cromoglycate on intranasal histamine challenge in allergic rhinitis. Clin Otolaryngol 1994; 19:521-525.
62. Melen I, Friberg B, Andreasson L, et al. Effects of phenylpropanolamine on ostial and nasal patency in patients treated for chronic maxillary sinusitis. Acta Otolaryngol 1986; 101:494-500.
63. Melen I, Andreasson L, Invarsson A, et al. Effects of phenylpropanolamine on ostial and nasal airway resistance in healthy individuals. Acta Otolaryngol 1986; 102:99-105.
64. Bende M, Loth S. Vascular effects of topical oxymetazoline on human nasal mucosa. J Laryngol Otol 1986; 100:285-288.
65. Wawrose SF, Tami TA, Amoils CP. The role of guaifenesin in the treatment of sinonasal disease in patients infected with human immunodeficiency virus (HIV). Laryngoscope 1992; 102:1225-1228.
66. Durham SR, Walker SM, Samantha M, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341:468-475.
67. Nishioka GJ, Cook PR, Davis WE, McKinsey JP. Immunotherapy in patients undergoing functional endoscopic sinus surgery. Otolaryngol Head Neck Surg 1994; 110:406-412.
68. Mabry RL, Marple BF, Folker RJ, Mabry CS. Immunotherapy for allergic fungal sinusitis: three years' experience. Otolaryngol Head Neck Surg 1998; 119:648-651.
69. Jiang RS, Hsu CY. Functional endoscopic sinus surgery in children and adults. Ann Otol Rhinol Laryngol 2000; 109:1113-1136.
70. Senior BA, Kennedy DW, Tanabodee J, et al. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998; 108:151-157.
71. Lavigne F, Nguyen CT, Cameron L, et al. Prognosis and prediction of response to surgery in allergic patients with chronic sinusitis. J Allergy Clin Immunol 2000; 105:746-751.